TY - JOUR
T1 - Fetal T cell activation in the amniotic cavity during preterm labor
T2 - A potential mechanism for a subset of idiopathic preterm birth
AU - Gomez-Lopez, Nardhy
AU - Romero, Roberto
AU - Xu, Yi
AU - Miller, Derek
AU - Arenas-Hernandez, Marcia
AU - Garcia-Flores, Valeria
AU - Panaitescu, Bogdan
AU - Galaz, Jose
AU - Hsu, Chaur Dong
AU - Para, Robert
AU - Berry, Stanley M.
N1 - Publisher Copyright:
Copyright Ó 2019 by The American Association of Immunologists,
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Prematurity is the leading cause of perinatal morbidity and mortality worldwide. In most cases, preterm birth is preceded by spontaneous preterm labor, a syndrome that is associated with intra-amniotic inflammation, the most studied etiology. However, the remaining etiologies of preterm labor are poorly understood; therefore, most preterm births are categorized as idiopathic. In this study, we provide evidence showing that the fetal immune system undergoes premature activation in women with preterm labor without intra-amniotic inflammation, providing a potential new mechanism of disease for some cases of idiopathic preterm birth. First, we showed that fetal T cells are a predominant leukocyte population in amniotic fluid during preterm gestations. Interestingly, only fetal CD4+ T cells were increased in amniotic fluid of women who underwent idiopathic preterm labor and birth. This increase in fetal CD4+ T cells was accompanied by elevated amniotic fluid concentrations of T cell cytokines such as IL-2, IL-4, and IL-13, which are produced by these cells upon in vitro stimulation, but was not associated with the prototypical cytokine profile observed in women with intra-amniotic inflammation. Also, we found that cord blood T cells, mainly CD4+ T cells, obtained from women with idiopathic preterm labor and birth displayed enhanced ex vivo activation, which is similar to that observed in women with intra-amniotic inflammation. Finally, we showed that the intra-amniotic administration of activated neonatal CD4+ T cells induces preterm birth in mice. Collectively, these findings provide evidence suggesting that fetal T cell activation is implicated in the pathogenesis of idiopathic preterm labor and birth.
AB - Prematurity is the leading cause of perinatal morbidity and mortality worldwide. In most cases, preterm birth is preceded by spontaneous preterm labor, a syndrome that is associated with intra-amniotic inflammation, the most studied etiology. However, the remaining etiologies of preterm labor are poorly understood; therefore, most preterm births are categorized as idiopathic. In this study, we provide evidence showing that the fetal immune system undergoes premature activation in women with preterm labor without intra-amniotic inflammation, providing a potential new mechanism of disease for some cases of idiopathic preterm birth. First, we showed that fetal T cells are a predominant leukocyte population in amniotic fluid during preterm gestations. Interestingly, only fetal CD4+ T cells were increased in amniotic fluid of women who underwent idiopathic preterm labor and birth. This increase in fetal CD4+ T cells was accompanied by elevated amniotic fluid concentrations of T cell cytokines such as IL-2, IL-4, and IL-13, which are produced by these cells upon in vitro stimulation, but was not associated with the prototypical cytokine profile observed in women with intra-amniotic inflammation. Also, we found that cord blood T cells, mainly CD4+ T cells, obtained from women with idiopathic preterm labor and birth displayed enhanced ex vivo activation, which is similar to that observed in women with intra-amniotic inflammation. Finally, we showed that the intra-amniotic administration of activated neonatal CD4+ T cells induces preterm birth in mice. Collectively, these findings provide evidence suggesting that fetal T cell activation is implicated in the pathogenesis of idiopathic preterm labor and birth.
UR - http://www.scopus.com/inward/record.url?scp=85072627598&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072627598&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1900621
DO - 10.4049/jimmunol.1900621
M3 - Article
C2 - 31492740
AN - SCOPUS:85072627598
SN - 0022-1767
VL - 203
SP - 1793
EP - 1807
JO - Journal of Immunology
JF - Journal of Immunology
IS - 7
ER -